Medical Technology Company Launches Fair Deal Agreement: Reports Major Revenue Increase
This patent enhances the company's intellectual property portfolio and reinforces its position as a leader in the dermatological treatment landscape.
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company known for its non-invasive, minimally invasive, and cost-effective treatments for oncological and non-oncological conditions, has unveiled its financial outcomes for the first quarter ended March 31, 2024. The results present a substantial revenue increase and underscore the successful launch of a novel recurring revenue program aimed at enhancing equipment accessibility and usage flexibility for healthcare providers. $Sensus Healthcare(SRTS.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
